Antonei B Csoka, PhD

Could deep brain stimulation change not only brain circuits, but also the genes that help those circuits communicate? This may be an important next chapter in deep brain stimulation (DBS). Gene expression refers to how brain cells turn specific genes on or off to influence their function. Neuronal assemblies are groups of brain cells that fire together to process information. Haley Moore and colleagues describe in a new paper in Nature how electrical stimulation of human brain tissue can strengthen coordinated neuronal activity and activate specific genetic programs involved in synaptic plasticity. The implications for the future of DBS are exciting. Key points: - Electrical stimulation strengthened neuronal assemblies, increasing coordinated firing and changing how neurons participated in functional brain networks. - Stimulation produced cell-type-specific changes in gene expression, particularly in excitatory neurons, involving genes such as FOS, EGR1, BDNF and HOMER1 that are linked to neuronal activity and synaptic function. - By combining electrical recordings and single-cell genomic analyses, the researchers connected stimulation-induced changes in brain activity to molecular pathways and identified related signatures following stimulation in living human brains. My take: This study resonates deeply w/ me because it challenges us to think beyond the traditional view that DBS works simply by turning abnormal brain circuits on or off. What if stimulation is also changing the biological machinery that determines how brain cells communicate, reorganize and adapt? We have long suspected that plasticity contributes to DBS outcomes, however directly linking stimulation, neuronal assemblies and gene regulation in human tissue represents an important advance. Could we eventually use molecular signatures to select better targets, personalize stimulation parameters and potentially promote more durable therapeutic effects? This is especially relevant as we move toward adaptive DBS, where stimulation responds to changing brain activity. We should remember that this was primarily a mechanistic study of human temporal cortex, not a clinical trial demonstrating improved Parkinson's outcomes or disease modification. Here are 5 points that resonated w/ me: 1- DBS may do more than interrupt abnormal signals. It may also reshape how brain cells organize into functional networks. 2- Not all neurons respond equally to stimulation. Understanding which cell types respond could help us develop more precise and personalized neuromodulation therapies. 3- Genes involved in synaptic plasticity may provide molecular biomarkers to better understand why some folks respond differently to DBS. 4- Combining electrophysiology, genomics and adaptive stimulation could help move DBS beyond symptom suppression toward therapies designed to influence circuit plasticity. Whether these changes can produce lasting clinical benefits remains an important unanswered question. 5- The future of DBS may require us to think at three interconnected levels: brain circuits, individual neurons and molecular biology. The opportunity is to understand not just where and when to stimulate, but what stimulation actually changes inside the brain. The big question: Could the next generation of DBS devices eventually be programmed not only to change brain activity, but also to engage the biological processes that help brain networks adapt and recover? nature.com/articles/s41586-0… @DBSThinkTank